Nasdaq: TARS
Tarsus Pharmaceuticals insiders
The officers, directors and 10% owners of Tarsus Pharmaceuticals, Inc. who hold the most stock, valued at the live TARS price.
$77.67
TARS today +$1.7M (+2.26%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 8
- Their TARS stock
- $253M
- Market value
- $3.81B
- Held by ranked insiders
- 6.65%
Insiders by value of TARS holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Bobak R. Azamian | President/CEO and Board Chair | 1,715,403 | $133M | 3.50% | 1209th |
| 2 | Michael Ackermann | Director | 1,308,273 | $102M | 2.67% | 1484th |
| 3 | William J. Link Phd | Director | 104,933 | $8.2M | 0.21% | 8039th |
| 4 | Seshadri Neervannan | Chief Operating Officer | 79,007 | $6.1M | 0.16% | 12564th |
| 5 | Leonard Greenstein | Chief Financial Officer | 26,785 | $2.1M | <0.1% | 13839th |
| 6 | Bhaskar Chaudhuri | Director | 11,654 | $905K | <0.1% | 4261st |
| 7 | David E. I. Pyott | Director | 10,958 | $851K | <0.1% | 9650th |
| 8 | Rosemary A. Crane | Director | 5,350 | $416K | <0.1% | 13039th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Tarsus Pharmaceuticals; see each profile for the filing.